Correlation of Insulin Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein with LH, FSH and Testosterone in Iraqi Children with Growth Hormone Deficiency
DOI:
https://doi.org/10.31699/IJCPE.2023.1.10Keywords:
Insulin like Growth Factor-1, Insulin-like Growth Factor Binding Protein.Abstract
Insulin like growth factor-1 has metabolic and growth-related roles all over the body and is strongly associated and regulated by growth hormone. It is produced by almost any type of tissue, especially the liver. The study aimed to measure insulin like growth factor in growth hormone deficient patients and find its relation with other studied parameters. The Subjects in the study were 180 studied in the National Diabetic Center for Treatment and Research/Al-Mustansiriya University in Baghdad/Iraq for the period from November 2021 to April 2022. Blood was drawn and investigated for the levels of IGF-1, IGFBP-3, LH, and FSH. Also testosterone and statistical analysis was carried out to find the potential correlations. The results relived that the gender was not affect the levels of either parameter, IGF-1 was found to be positively correlated with age, BMI, and IGFBP-3. While IGFBP-3 was found to be positively correlated with the levels of IGF-1, LH, FSH and testosterone. From the results of the current study, it can be concluded that the levels of GH as well as the levels of IGF-1 and IGFBP-3, have significant difference between the NGHD and the patients’ group.
Received on 30/09/2022
Received in Revised Form on 14/11/2022
Accepted on 17/11/2022
Published on 30/03/2023
References
Z. Laron, “Insulin-like growth factor 1 (IGF-1): a growth hormone,” Mol. Pathol., vol. 54, no. 5, p. 311, 2001, http://dx.doi.org/10.1136/mp.54.5.311.
C. Ohlsson et al., “The role of liver-derived insulin-like growth factor-I,” Endocr. Rev., vol. 30, no. 5, pp. 494–535, 2009, https://doi.org/10.1210/er.2009-0010.
C. A. Bondy and C. M. Cheng, “Signaling by insulin-like growth factor 1 in brain,” Eur. J. Pharmacol., vol. 490, no. 1–3, pp. 25–31, 2004, https://doi.org/10.1016/j.ejphar.2004.02.042.
J. E. Puche, M. García-Fernández, J. Muntane, J. Rioja, S. Gonzalez-Baron, and I. Castilla Cortazar, “Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats,” Endocrinology, vol. 149, no. 5, pp. 2620–2627, 2008, https://doi.org/10.1210/en.2007-1563.
M. García-Fernández, J. E. Puche, G. Delgado, S. González-Barón, and I. Castilla-Cortázar, “149 insulin-like growth factor-i (IGF-I) reduces the impact of age in oxidative liver damage and restores insulin resistance and lipid metabolism,” J. Hepatol., no. 48, pp. S65–S66, 2008, http://doi.org/10.1016/S0168-8278(08)60151-8.
N. A. D. Al-garawi, A. A. Suhail, H. A. Kareem, and G. S. Bustani, “Study of Lipid Profile and Leptin hormone and Adiponectin hormone hypertensive patients in Najaf Governorate,” Rev. Electron. Vet., pp. 45–51, 2022.
J. Wang, J. Zhou, C. M. Cheng, J. J. Kopchick, and C. A. Bondy, “Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth,” J. Endocrinol., vol. 180, no. 2, pp. 247–256, 2004, https://doi.org/10.1677/joe.0.1800247.
R. C. Baxter, “Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities,” Am. J. Physiol. Metab., vol. 278, no. 6, pp. E967–E976, 2000, https://doi.org/10.1152/ajpendo.2000.278.6.E967.
S. Varma Shrivastav, A. Bhardwaj, K. A. Pathak, and A. Shrivastav, “Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell,” Front. Cell Dev. Biol., vol. 8, p. 286, 2020, https://doi.org/10.3389/fcell.2020.00286.
K. A. Marzec, R. C. Baxter, and J. L. Martin, “Targeting insulin-like growth factor binding protein-3 signaling in triple-negative breast cancer,” Biomed Res. Int., vol. 2015, 2015, https://doi.org/10.1155/2015/638526.
F.-M. Chen and Y. Jin, “Periodontal tissue engineering and regeneration: current approaches and expanding opportunities,” Tissue Eng. Part B Rev., vol. 16, no. 2, pp. 219–255, 2010, https://doi.org/10.1089/ten.teb.2009.0562.
N. R. Carlson, “Physiology of Behavior. Reproductive Behavior.” Pearson, 2012.
V. A. Randall, “Androgens and hair,” in Testosterone, Springer, 1998, pp. 169–186, https://doi.org/10.1007/978-3-642-72185-4_5.
G. Manukyan et al., “17β-Estradiol Promotes Proinflammatory and Procoagulatory Phenotype of Innate Immune Cells in the Presence of Antiphospholipid Antibodies,” Biomedicines, vol. 8, no. 6, p. 162, 2020, https://doi.org/10.3390/biomedicines8060162.
J. Cui, Y. Shen, and R. Li, “Estrogen synthesis and signaling pathways during aging: from periphery to brain,” Trends Mol. Med., vol. 19, no. 3, pp. 197–209, 2013, https://doi.org/10.1016/j.molmed.2012.12.007.
H. Zhang, K. Taya, K. Nagaoka, M. Yoshida, and G. Watanabe, “Neonatal exposure to 17α-ethynyl estradiol (EE) disrupts follicle development and reproductive hormone profiles in female rats,” Toxicol. Lett., vol. 276, pp. 92–99, 2017, https://doi.org/10.1016/j.toxlet.2017.05.014.
G. Jasienska, S. F. Lipson, P. T. Ellison, I. Thune, and A. Ziomkiewicz, “Symmetrical women have higher potential fertility,” Evol. Hum. Behav., vol. 27, no. 5, pp. 390–400, 2006, https://doi.org/10.1016/j.evolhumbehav.2006.01.001.
S. Taraborrelli, “Physiology, production and action of progesterone,” Acta Obstet. Gynecol. Scand., vol. 94, pp. 8–16, 2015, https://doi.org/10.1111/aogs.12771.
D. Nedresky and G. Singh, “Physiology, luteinizing hormone,” in StatPearls, StatPearls Publishing, 2021.
S. Ilahi and T. B. Ilahi, “Anatomy, Adenohypophysis (Pars Anterior, Anterior Pituitary),” in StatPearls, StatPearls Publishing, 2021.
M. J. Horney, Inhibition of insulin-like growth factor (IGF)-1 by IGF binding protein-2: Functional and structural aspects. Medical University of South Carolina, 2001.
A. Pasqualini et al., “Efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime®) vs. Gonal-f® in women undergoing ovarian stimulation for IVF: A randomized, multicenter, evaluator-blinded, non-inferiority study,” JBRA Assist. Reprod., vol. 25, no. 4, p. 524, 2021, http://doi.org/10.5935/1518-0557.20210023.
S. Vafaei, F. Motejaded, and A. Ebrahimzadeh-Bideskan, “Protective effect of crocin on electromagnetic field-induced testicular damage and heat shock protein A2 expression in male BALB/c mice,” Iran. J. Basic Med. Sci., vol. 23, no. 1, p. 102, 2020, http://doi.org/10.22038/IJBMS.2019.38896.9229.
K. M. J. A. Claessen et al., “Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy,” J. Clin. Endocrinol. Metab., vol. 98, no. 1, pp. 352–361, 2013, https://doi.org/10.1210/jc.2012-2940.
S. E. Myers, B. Y. Whitman, A. L. Carrel, V. Moerchen, M. T. Bekx, and D. B. Allen, “Two years of growth hormone therapy in young children with Prader–Willi syndrome: physical and neurodevelopmental benefits,” Am. J. Med. Genet. Part A, vol. 143, no. 5, pp. 443–448, 2007, https://doi.org/10.1002/ajmg.a.31468.
A. L. Carrel, V. Moerchen, S. E. Myers, M. T. Bekx, B. Y. Whitman, and D. B. Allen, “Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome,” J. Pediatr., vol. 145, no. 6, pp. 744–749, 2004, https://doi.org/10.1016/j.jpeds.2004.08.002.
M. Brada, S. Ashley, D. Ford, D. Traish, L. Burchell, and B. Rajan, “Cerebrovascular mortality in patients with pituitary adenoma,” Clin. Endocrinol. (Oxf)., vol. 57, no. 6, pp. 713–717, 2002, https://doi.org/10.1046/j.1365-2265.2002.01570.x.
W. Liu et al., “Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis,” J. Ethnopharmacol., vol. 277, p. 113789, 2021, https://doi.org/10.1016/j.jep.2021.113789.
L. B. Esberg, X. Zhang, G. I. Scott, B. Culver, and J. Ren, “Impact of gender on basal and insulin-like growth factor I-regulated nitric oxide synthase activity in adult rat left ventricular myocytes,” Comp. Biochem. Physiol. Part A Mol. Integr. Physiol., vol. 138, no. 2, pp. 141–146, 2004, https://doi.org/10.1016/j.cbpb.2004.02.022.
M. Toumba, A. Albanese, C. Azcona, and R. Stanhope, “Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome,” Horm. Res. Paediatr., vol. 74, no. 3, pp. 212–217, 2010, https://doi.org/10.1159/000295924.
A. Giustina et al., “Criteria for cure of acromegaly: a consensus statement,” J. Clin. Endocrinol. Metab., vol. 85, no. 2, pp. 526–529, 2000, https://doi.org/10.1210/jcem.85.2.6363.
L. K. Roper, J. S. Briguglio, C. S. Evans, M. B. Jackson, and E. R. Chapman, “Sex-specific regulation of follicle-stimulating hormone secretion by synaptotagmin 9,” Nat. Commun., vol. 6, no. 1, pp. 1–10, 2015, https://doi.org/10.1038/ncomms9645.
J. Durdiakova, D. Ostatnikova, and P. Celec, “Testosterone and its metabolites—Modulators of brain functions.,” Acta Neurobiol. Exp. (Wars)., 2011.
J. E. Puche and I. Castilla-Cortázar, “Human conditions of insulin-like growth factor-I (IGF-I) deficiency,” J. Transl. Med., vol. 10, no. 1, pp. 1–29, 2012, https://doi.org/10.1186/1479-5876-10-224.
S. Gubbi, G. F. Quipildor, N. Barzilai, D. M. Huffman, and S. Milman, “40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain,” J. Mol. Endocrinol., vol. 61, no. 1, pp. T171–T185, 2018.
M. S. Lewitt, M. S. Dent, and K. Hall, “The insulin-like growth factor system in obesity, insulin resistance and type 2 diabetes mellitus,” J. Clin. Med., vol. 3, no. 4, pp. 1561–1574, 2014, https://doi.org/10.3390/jcm3041561.
T. E. Hormones and B. C. C. Group, “Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies,” Lancet Oncol., vol. 11, no. 6, pp. 530–542, 2010, https://doi.org/10.1016/S1470-2045(10)70095-4.
Y. Wang, H. Zhang, M. Cao, L. Kong, and X. Ge, “Analysis of the value and correlation of IGF‑1 with GH and IGFBP‑3 in the diagnosis of dwarfism,” Exp. Ther. Med., vol. 17, no. 5, pp. 3689–3693, 2019, https://doi.org/10.3892/etm.2019.7393.
C. L. Adam, T. S. Gadd, P. A. Findlay, and D. C. Wathes, “IGF-I stimulation of luteinizing hormone secretion, IGF-binding proteins (IGFBPs) and expression of mRNAs for IGFs, IGF receptors and IGFBPs in the ovine pituitary gland,” J. Endocrinol., vol. 166, no. 2, pp. 247–254, 2000, http://doi.org/10.1677/joe.0.1660247.
T. Adachi, M. Iwashita, A. Kuroshima, and Y. Takeda, “Regulation of IGF binding proteins by FSH in human luteinizing granulosa cells,” J. Assist. Reprod. Genet., vol. 12, no. 9, pp. 639–643, 1995, https://doi.org/10.1007/BF02212589.
J. M. Gross, “Insulin-Like Growth Factor Binding Protein-1 Interacts with Integrins to Inhibit Insulin-Like Growth Factor-Induced Breast Cancer Growth and Migration,” MINNESOTA UNIV MINNEAPOLIS, 2003.
P. J. Wysocki and B. Wierusz-Wysocka, “Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin,” Expert Rev. Mol. Diagn., vol. 10, no. 4, pp. 509–519, 2010, https://doi.org/10.1586/erm.10.22.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Chemical and Petroleum Engineering
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
